What does Ovo Labs do?
Ovo Labs is a UK-based biotechnology company that develops a series of innovative therapeutics targeting molecular mechanisms involved in egg cell division, aiming to enhance IVF outcomes for women.
How much did they raise?
The company raised £4M in a funding round led by Creator Fund and LocalGlobe with participation from Blue Wire Capital, Ahren Innovation Capital, and Antonio Pellicer.
What are their plans for the money?
Ovo Labs plans to use the funds to expand its operations and intensify its research and development efforts, potentially leading to significant improvements in infertility treatments.
What have they achieved so far?
Co-founded by Professor Melina Schuh, Dr Agata Zielinska, and Dr Oleksandr Yagensky, the company has already made notable progress in developing therapeutics designed to innovate infertility treatment since the advent of IVF.
